The average 12-month price target for REGENXBIO Inc. (RGNX) stock has increased from $25.58 to $26.08, according to estimates from 12 analysts. This n...
Neutral
Propel Bio Management LLC purchased a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX – Free Report) in the 4th quarter, Holdings Channel.com re...
Neutral
JPMorgan Chase & Co. and its affiliates have reported a 4.4% beneficial ownership stake in REGENXBIO Inc. (NCUSIP 75901B107), amounting to 2,279,362 s...